Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

BACKGROUND: The PET-derived metabolic tumor volume (MTV) is an independent prognosticator in non-small cell lung cancer (NSCLC) patients. We analyzed the prognostic value of residual MTV (rMTV) after completion of chemoradiotherapy (CRT) in inoperable stage III NSCLC patients with and without immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Unterrainer, Marcus, Taugner, Julian, Käsmann, Lukas, Tufman, Amanda, Reinmuth, Niels, Li, Minglun, Mittlmeier, Lena M., Bartenstein, Peter, Kunz, Wolfgang G., Ricke, Jens, Belka, Claus, Eze, Chukwuka, Manapov, Farkhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921088/
https://www.ncbi.nlm.nih.gov/pubmed/34664091
http://dx.doi.org/10.1007/s00259-021-05584-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921088/
https://www.ncbi.nlm.nih.gov/pubmed/34664091
http://dx.doi.org/10.1007/s00259-021-05584-w

Ejemplares similares